Related Experiment Videos
[Stereotactic biopsy for intracranial deep lesions]
Zonghui Liu1, Xin Yu, Shiyue Li
1Department of Neurosurgery, Navy General Hospital of People's Liberation Army, Beijing 100037, China.
Zhonghua Yi Xue Za Zhi
|April 16, 2002
Summary
Stereotactic biopsy guided by CT or MRI is effective for diagnosing deep brain lesions. This safe and reliable method achieved a high diagnostic positive rate of 96.69%.
Area of Science:
- Neurosurgery
- Neuropathology
- Medical Imaging
Context:
- Deep-seated intracranial lesions pose diagnostic challenges.
- Accurate histological diagnosis is crucial for effective treatment planning.
Purpose:
- To evaluate the diagnostic efficacy and accuracy of stereotactic biopsy for intracranial deep lesions.
- To assess the safety and reliability of CT- and MRI-guided stereotactic biopsy.
Summary:
- Stereotactic biopsy was performed in 605 cases using CT or MRI guidance.
- The overall positive diagnostic rate was 96.69%, with high accuracy for brain tumors and inflammatory lesions.
- Complication rates were low (2.98%), with a mortality rate of 0.33%.
Impact:
- Stereotactic biopsy is a safe and reliable method for histological diagnosis of deep intracranial lesions.
- This technique enhances diagnostic capabilities in neurosurgery.
- Provides essential pathological information for patient management.